Locus Biosciences: Funding, Investors & Team (Oct 2026)
Locus Biosciences is a company that has developed a precision antibacterial platform using CRISPR technology, with the aim of completely transforming how bacterial diseases are treated. By merging the potent antibacterial capabilities of CRISPR-Cas3 with the effective and safe delivery of bacteriophages (bacterial viruses), the platform allows doctors to initiate treatment faster, ultimately leading to improved medical results.
Locus Biosciences has raised $94.4M across 4 funding rounds on record, the most recent an undisclosed round of $23.9M announced in Jan 2024.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Locus Biosciences Company Profile and Key Stats
Latest funding round on record: Jan 2024.
Locus Biosciences Funding Rounds
Locus Biosciences raised $25.0M in a Debt Financing announced in Oct 2021.
4 months later, an undisclosed round of $10.5M was announced in Feb 2022.
3 months later, a Series B of $35.0M was announced in May 2022.
1.7 years later, an undisclosed round of $23.9M was announced in Jan 2024.
Locus Biosciences Founders and Leadership Team
Contact details for the Locus Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Locus Biosciences Funding Compared to Other Biotechnology Startups
Locus Biosciences' latest round of $23.9M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Locus Biosciences in Biotechnology and Morrisville
Companies Similar to Locus Biosciences
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Locus Biosciences Funding FAQs
What does Locus Biosciences do?
Locus Biosciences is a company that has developed a precision antibacterial platform using CRISPR technology, with the aim of completely transforming how bacterial diseases are treated. By merging the potent antibacterial capabilities of CRISPR-Cas3 with the effective and safe delivery of bacteriophages (bacterial viruses), the platform allows doctors to initiate treatment faster, ultimately leading to improved medical results.
How much funding has Locus Biosciences raised?
Locus Biosciences has raised $94.4M across 4 rounds on record. The most recent is an undisclosed round of $23.9M announced in Jan 2024.
When did Locus Biosciences last raise funding?
Locus Biosciences' most recent funding round on record is an undisclosed round of $23.9M, announced in Jan 2024.
Who is the CEO of Locus Biosciences?
Paul Garofolo is listed as CEO at Locus Biosciences.
Where is Locus Biosciences headquartered?
Locus Biosciences is based in Morrisville, North Carolina, United States.
How many employees does Locus Biosciences have?
Locus Biosciences is in the 51-100 employee band.
How does Locus Biosciences' funding compare to other Biotechnology startups?
Locus Biosciences' latest round of $23.9M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Locus Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Locus Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.